RxDoctor Payments Data

Daniel Craviotto, MD

Orthopaedic Surgery · Santa Barbara, CANPI 1083794291

Payments from drug & device makers

$1,545in general payments, 2019–2025

Across 20 payments — averaging $77.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$583
  • Naviswiss, Inc.$242
  • Stryker$241
  • Smith+Nephew$139
  • Zimmer Biomet$112
  • Illuminoss Medical, Inc.$93
  • plus $135 from 4 others

What the payments were for

  • Food & beverage$1,545100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson9$583
Naviswiss, Inc.1$242
Stryker3$241
Smith+Nephew1$139
Zimmer Biomet1$112
Illuminoss Medical, Inc.1$93
Cornerstone Medical Associates, Inc.1$53
Arthrex1$46
Si-bone, Inc.1$23
Encore Medical, LP1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,545 in reported general payments places this provider in the 40th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$267,809
Medicare patients
519
Services billed
3,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen97$1,866
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85$1,284
Celecoxib23$1,206
Doxycycline Hyclate13$341
Meloxicam68$285
Amoxicillin83$193
Cephalexin38$113
Tramadol Hcl31$86

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Santa Barbara

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →